These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34116198)

  • 1. Infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use.
    Labella MH; Eiden RD; Tabachnick AR; Sellers T; Dozier M
    Neurotoxicol Teratol; 2021; 86():107000. PubMed ID: 34116198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-month follow-up of infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use.
    Bierce L; Tabachnick AR; Eiden RD; Dozier M; Labella MH
    Neurotoxicol Teratol; 2023; 97():107176. PubMed ID: 37054901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry.
    Grecco GG; Mork BE; Huang JY; Metzger CE; Haggerty DL; Reeves KC; Gao Y; Hoffman H; Katner SN; Masters AR; Morris CW; Newell EA; Engleman EA; Baucum AJ; Kim J; Yamamoto BK; Allen MR; Wu YC; Lu HC; Sheets PL; Atwood BK
    Elife; 2021 Mar; 10():. PubMed ID: 33724184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis.
    Nelson LF; Yocum VK; Patel KD; Qeadan F; Hsi A; Weitzen S
    JAMA Netw Open; 2020 Mar; 3(3):e201195. PubMed ID: 32186745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population.
    Azuine RE; Ji Y; Chang HY; Kim Y; Ji H; DiBari J; Hong X; Wang G; Singh GK; Pearson C; Zuckerman B; Surkan PJ; Wang X
    JAMA Netw Open; 2019 Jun; 2(6):e196405. PubMed ID: 31251378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children.
    Trønnes JN; Lupattelli A; Handal M; Skurtveit S; Ystrom E; Nordeng H
    JAMA Netw Open; 2021 Sep; 4(9):e2124324. PubMed ID: 34524436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal buprenorphine treatment and infant outcome.
    Jansson LM; Velez ML; McConnell K; Spencer N; Tuten M; Jones H; Rios R; King VL; Gandotra N; Millio L; DiPietro JA
    Drug Alcohol Depend; 2017 Nov; 180():56-61. PubMed ID: 28869859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
    Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
    Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal abstinence syndrome: treatment and pediatric outcomes.
    Logan BA; Brown MS; Hayes MJ
    Clin Obstet Gynecol; 2013 Mar; 56(1):186-92. PubMed ID: 23314720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MATernaL and Infant NetworK to Understand Outcomes Associated with Treatment of Opioid Use Disorder During Pregnancy (MAT-LINK): Surveillance Opportunity.
    Tran EL; Kim SY; England LJ; Green C; Dang EP; Broussard CS; Fehrenbach N; Hudson A; Yowe-Conley T; Gilboa SM; Meaney-Delman D
    J Womens Health (Larchmt); 2020 Dec; 29(12):1491-1499. PubMed ID: 33227221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity Disorder.
    Garrison-Desany HM; Hong X; Maher BS; Beaty TH; Wang G; Pearson C; Liang L; Wang X; Ladd-Acosta C
    JAMA Netw Open; 2022 Mar; 5(3):e221957. PubMed ID: 35275164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal methadone exposure and child developmental outcomes in 2-year-old children.
    Levine TA; Davie-Gray A; Kim HM; Lee SJ; Woodward LJ
    Dev Med Child Neurol; 2021 Sep; 63(9):1114-1122. PubMed ID: 33462809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic.
    Skurtveit S; Nechanská B; Handal M; Mahic M; Mravčík V; Gabrhelík R
    Addiction; 2019 Jul; 114(7):1225-1235. PubMed ID: 30725515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment.
    Winklbaur B; Baewert A; Jagsch R; Rohrmeister K; Metz V; Aeschbach Jachmann C; Thau K; Fischer G
    Eur Addict Res; 2009; 15(3):150-6. PubMed ID: 19420947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.
    Wang S; Meador KJ; Pawasauskas J; Lewkowitz AK; Ward KE; Brothers TN; Hartzema A; Quilliam BJ; Wen X
    Drug Saf; 2023 Mar; 46(3):257-271. PubMed ID: 36642778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study.
    Meador KJ; Cohen MJ; Loring DW; May RC; Brown C; Robalino CP; Matthews AG; Kalayjian LA; Gerard EE; Gedzelman ER; Penovich PE; Cavitt J; Hwang S; Sam M; Pack AM; French J; Tsai JJ; Pennell PB;
    JAMA Neurol; 2021 Aug; 78(8):927-936. PubMed ID: 34096986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers.
    McLaughlin P; Mactier H; Gillis C; Hickish T; Parker A; Liang WJ; Osselton MD
    J Pediatr; 2017 Nov; 190():180-184.e1. PubMed ID: 28867064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of Maternal Prenatal Drug Abuse With Measures of Newborn Brain Structure, Tissue Organization, and Metabolite Concentrations.
    Peterson BS; Rosen T; Dingman S; Toth ZR; Sawardekar S; Hao X; Liu F; Xu D; Dong Z; Peterson JB; Ryoo JH; Serino D; Branch CA; Bansal R
    JAMA Pediatr; 2020 Sep; 174(9):831-842. PubMed ID: 32539126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.
    Wilder C; Lewis D; Winhusen T
    Drug Alcohol Depend; 2015 Apr; 149():225-31. PubMed ID: 25735465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.